Reconsidering the Concept of First-Line, High-Efficacy Treatment

Reconsidering the Concept of First-Line, High-Efficacy Treat...

On the Frontlines of Multiple Sclerosis

Share Podcast:
Host: Prof. Hans Peter Hartung In the management of multiple sclerosis there are essentially two therapeutic approaches. The first is a high-efficacy treatment typically reserved for patients with severe disease and a high number of relapses; the second is a slowly intensifying approach known as escalation in which less efficacious treatments are assessed before escalating to a second or third drug. High efficacy treatment comes with a higher ris...
Read More
Host: Prof. Hans Peter Hartung In the management of multiple sclerosis there are essentially two therapeutic approaches. The first is a high-efficacy treatment typically reserved for patients with severe disease and a high number of relapses; the second is a slowly intensifying approach known as escalation in which less efficacious treatments are assessed before escalating to a second or third drug. High efficacy treatment comes with a higher ris...
Read More